Frequency of Infusion-Related Reactions with CPX-351 Treatment in an Observational Study in Adults with Newly Diagnosed Therapy-Related AML or AML with Myelodysplasia-Related Changes (AML-MRC)

Authors

Meagan A. Jacoby
Laura Finn
Ashkan Emadi
Nakhle S. Saba
Bayard L. Powell
Karen Seiter, New York Medical CollegeFollow
Rosella Garcia
Stefan Faderl
Heather J. Male

Author Type(s)

Faculty

Journal Title

Leukemia & Lymphoma

First Page

2539

Last Page

2542

Document Type

Article

Publication Date

10-2021

Department

Medicine

Recommended Citation

Jacoby, M. A., Finn, L., Emadi, A., Saba, N. S., Powell, B. L., Seiter, K., Garcia, R., Faderl, S., & Male, H. J. (2021). Frequency of Infusion-Related Reactions with CPX-351 Treatment in an Observational Study in Adults with Newly Diagnosed Therapy-Related AML or AML with Myelodysplasia-Related Changes (AML-MRC). Leukemia & Lymphoma, 62 (10), 2539-2542. https://doi.org/10.1080/10428194.2021.1919668